heparanase inhibitors (Beta Therapeutics)

N/A

Report date: 2025/01/26 18:04:13
NME

Base Information

Drug Nameheparanase inhibitors (Beta Therapeutics)
Drug Alias NameBT-2180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeparanase inhibitors
TargetsHeparanase
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeta Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A